Association between the Adaptive Immune System and Immune Checkpoints and Response to Pertuzumab and Trastuzumab


Association between the Adaptive Immune System and Immune Checkpoints and Response to Pertuzumab and Trastuzumab
Slides from a presentation at SABCS 2012 and transcribed comments from a recent interview with Lisa A Carey, MD (1/17/13)

Gianni L et al. Adaptive immune system and immune checkpoints are associated with response to pertuzumab (P) and trastuzumab (H) in the NeoSphere study. San Antonio Breast Cancer Symposium 2012;Abstract S6-7.

Dr Carey is Richardson and Marilyn Jacobs Preyer Distinguished Professor for Breast Cancer Research, Chief of the Division of Hematology and Oncology, Physician-in-Chief at the North Carolina Cancer Hospital and Associate Director for Clinical Research at the Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina.